Title Uloga adhezijskih molekula ICAM-1 i VCAM-1 u nastajanju psorijaze : doktorska disertacija
Author Leo Čabrijan
Mentor Jasna Lipozenčić (mentor)
Committee member Gordana Zamolo (predsjednik povjerenstva)
Committee member Marija Kaštelan (član povjerenstva)
Committee member Vesna Barac-Latas (član povjerenstva)
Granter University of Rijeka Faculty of Medicine Rijeka
Defense date and country 2009-08-06, Croatia
Scientific / art field, discipline and subdiscipline BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences
Universal decimal classification (UDC ) 616 - Pathology. Clinical medicine
Abstract Uvod
Psorijaza je upalna sustavna Th1 citokinska kožna bolest. U psorijatičnom
epidermisu je vodeća promjena keratinocitna proliferacija povezana s upalnim
promjenama, a očita je i uloga imunološkog sustava (prisutnost velikog broja
aktiviranih limfocita T u epidermisu i dermisu, kao i povezanost psorijaze s razredom
I HLA sustava). Drži se da je antigena stimulacija limfocita T u epidermisu preko
razreda I HLA unutar kojeg se određuje vezivanje peptida i predodžba T stanicama
ključna u imunosnom odgovoru (CD4+ i CD8+). Aktivirane T-stanice izlučuju brojne
Th1 citokine (interleukin 2-IL-2, γ interferon –INF-γ, tumor necrosis factor α – TNF-α,
interleukin 6 – IL-6) koji potiču keratinocitnu proliferaciju. Nova istraživanja govore o
važnosti adhezijskih molekula ICAM-1 i VCAM-1 u nastajanju psorijaze. U ovom radu
dokazana je njihova pojavnost u psorijatičnoj promijenjenoj i nepromijenjenoj koži.
Unatrag deset godina primjenjuje se i imunoterapija protutijelima protiv odgovarajućih
molekula koje sudjeluju u lancu imunoloških zbivanja u nastanku psorijaze.
Cilj istraživanja
Usporediti pojavnost aktiviranih limfocita T te makrofaga 68 i adhezijskih molekula:
intercelularne adhezijske molekule-1 (ICAM-1), vaskularne adhezijske molekule-1
(VCAM-1) te interleukin-2 receptora (IL-2r), u promijenjenoj i nepromijenjenoj koži
ispitanika sa psorijazom s nalazom u koži zdravih ispitanika, kao kontrolne skupine.
Na temelju tih nalaza, ukoliko ima razlike u pojavnosti u odnosu na zdravu kožu,
dokazati njihovu ulogu u etiopatogenezi psorijaze.
Materijal i metode
U ovome radu učinjena je probatorna biopsija kože 50 ispitanika sa psorijazom, kod
kojih je uzet uzorak promijenjene kože i nepromijenjene kože najmanje 5 cm
udaljene od ruba promijenjene kože, bolesnika koji četrnaest dana nisu koristili
sustavnu niti lokalnu terapiju protiv psorijaze. Uzet je uzorak kože kontrole skupine
50 ispitanika sa zdravom kožom. Potom su svježe smrznuti rezovi u fiziološkoj
otopini obrađeni u Zavodu za patologiju Medicinskog fakulteta Sveučilišta u Rijeci.
Standardnim imunohistokemijskim postupkom izvršeno je bojenje tkiva kitovima
tvrtke DAKO, za adhezijske molekule ICAM-1 i VCAM-1, a zatim očitavanje i limfocita
CD4 i CD8, te CD68+ makrofaga , te IL-2r kitovima s Medicinskog fakulteta Sveučilišta u Rijeci. Statističku obradu podataka izvršili su statističari Medicinskog
fakulteta Sveučilišta u Rijeci.
Rezultati
Prema rezultatima ovoga rada utvrđena je statistički značajna razlika u pojavnosti
ICAM-1 molekule iz promijenjene i nepromijenjene kože ispitanika sa psorijazom
(p<0,001) u odnosu na (zdravu) kožu kontrolne skupine. Također je statistički
značajna razlika u pojavnosti molekule VCAM-1 u odnosu na kožu kontrole (zdravih
ispitanika) (p<0,0001). Isto tako, uočena je značajna razlika u usporedbi IL-2r u
promijenjenoj koži ispitanika sa psorijazom u odnosu na kontrolnu skupinu (zdravih)
ispitanika (p<0,001).
Limfociti CD4 i CD8 su nađeni u većem broju ukupno u epidermisu i dermisu u
promijenjenoj koži ispitanika sa psorijazom u usporedbi s kontrolom (p<0,001). Isto
tako uočena je povećana izražajnost CD68+ makrofaga u promijenjenoj koži
ispitanika sa psorijazom u usporedbi s kontrolom (p<0,001).
Zaključak
Prema rezultatima rada kao i prema nekim drugima autorima, utvrđena je statistički
značajna razlika u pojavnosti adhezijskih molekula u koži ispitanika sa psorijazom i to
u promijenjenoj i nepromijenjenoj koži u usporedbi sa kontrolom, čime je dokazana
njihova važnost u etiopatogenezi psorijaze i u slijedu imunoloških zbivanja u koži
ispitanika sa psorijazom. Važno je istaknuti da se nepromijenjena koža ispitanika sa
psorijazom nalazi u «stanju pripravnosti» i u svakom trenutku može nastati promjena
na koži zbog visokih nalaza adhezijskih molekula u nepromijenjenoj koži ispitanika sa
psorijazom. Smatramo da bi odgovarajuća imunološka terapija protutijelima mogla
biti učinkovita u liječenju psorijaze.
Abstract (english) Psoriasis vulgaris is a systemic Th1 cytokine-mediated skin disease. In psoriatic
epidermis, the leading change is proliferation of keratinocytes associated with
inflammation. The role of immunologic reactions is obvious through the presence of
many activated T lymphocytes in epidermis and dermis and also association with
HLA class I antigen. Stimulation of T lymphocytes in epidermis by peptide antigens
presented in connection with HLA class I molecules is assumed to be the key event
in immune response (CD4 and CD8) activation. Activated T lymphocytes secret
many cytokines that stimulate keratinocyte proliferation such as interleukin 2 -IL-2, γ
interferon -IFN-γ, tumor necrosis factor α -TNF-α, interleukin 6 -IL-6. Recent research
data suggest the significance of adhesion molecules ICAM-1 and VCAM-1 in the
development of psoriasis. In this study we have shown their expression in psoriatic
lesional and non-lesional skin. During the last ten years immunotherapy with
monoclonal antibodies directed against molecules involved in immunologic process
has been used successfully in these patients.
Aim
The aim of this study was to determine the presence of activated T lymphocytes,
macrophage 68 and adhesion molecules: intercellular adhesion molecule-1 (ICAM-
1), vascular adhesion molecule-1 (VCAM-1) and interleukin-2 receptor (IL-2R) in
lesional and non-lesional psoriatic skin as compared with healthy skin in control
group in order to evaluate the possible differences as compared with healthy skin
and determine the role of adhesion molecules in etiopathogenesis of psoriasis.
Materials and methods
Skin biopsies of lesional and non-lesional skin at least 5 cm from lesion were
performed in 50 patients with psoriasis that have used no topical or systemic therapy
during at least two weeks prior biopsy. Skin biopsies of healthy skin were performed
in 50 healthy volunteers. All fresh frozen sections were examined histologically and
immunohistochemically at the Department of Pathology Medical Faculty University of
Rijeka. Standard immunohistochemical procedure using DAKO kits and IL-2R kit of
Medical Faculty University of Rijeka followed by the molecule expression reading in
order to evaluate the expression of lymphocyte markers, IL-2R and adhesion molecules (Olympus BX 51). Statistical analyses were performed at Medical Faculty
University of Rijeka.
Results
We have detected statistically significant difference of ICAM-1 expression in lesional
and non-lesional skin in psoriatic patients (p<0,001) in comparison with healthy skin
of our volunteers. Also, we have found statistically significant difference in adhesion
molecule VCAM-1 expression in comparison with healthy volunteers (p<0,0001).
Significant difference was detected in IL-2R expression between lesional psoriatic
skin and healthy skin of examined volunteers (p<0,001).
CD4 and CD8 lymphocytes were found in epidermis and dermis in augmented
number in lesional skin of psoriatic patients as compared with healthy volunteers
(p<0,001). Also, increased expression of CD68+ molecule, a macrophages marker,
was found in lesional skin of psoriatic patients in comparison with skin of healthy
volunteers (p<0,001).
Conclusion
According to obtained results and previously published studies, we have established
a significant difference in expression of adhesion molecules between lesional skin
and in non-lesional skin of psoriatic patients in comparison with healthy skin. These
results prove their importance in etiopathogenesis and immunologic events involved
in development of psoriatic lesions. It is important to emphasize that non-lesional skin
in psoriatic patients is in «stand by» position and in each moment could become
lesional, due to high levels of adhesion molecules expressed in non-lesional skin of
these patients. We can assume that targeted biologic therapy with specific
monoclonal antibodies could improve the treatment of psoriasis vulgaris.
Keywords
stacionarna psorijaza
adhezijske molekule (ICAM-1 i VCAM-1) u psorijaze
receptor za interleukin 2
makrofag CD68+
citotoksični limfociti (CD8)
pomoćnički limfociti (CD4)
Keywords (english)
stationary psoriasis
adhesion molecules (ICAM-1
VCAM-1) in psoriasis
IL-2R
macrophage CD68+
cytotoxic lymphocytes (CD)
T helper lymphocytes (CD4)
Language croatian
URN:NBN urn:nbn:hr:188:858046
Project Number: 0062040 Title: Imunopatogenetski mehanizmi u papuloskvamoznim kožnim bolestima Leader: Franjo Gruber Jurisdiction: Croatia Funder: MZOS
Study programme Title: Biomedicine Postgraduate (doctoral) study programme Study programme type: university Study level: postgraduate Academic / professional title: doktor/doktorica znanosti, područje biomedicine i zdravstvo (doktor/doktorica znanosti, područje biomedicine i zdravstvo)
Catalog URL http://libraries.uniri.hr/cgi-bin/ucat/unilib.cgi?form=D1120322023
Type of resource Text
Extent 124 str.
File origin Born digital
Access conditions Closed access
Terms of use
Public note Pohranjen je cjeloviti tekst rada, slike se nalaze na kraju tekstualnog dijela.
Created on 2017-01-19 18:47:44